Comment on 'Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells'
Related Experiment Videos
Breast Cancer Research and Treatment
|September 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
GLP-1 receptor agonist-associated weight loss in breast cancer patients receiving concurrent endocrine therapy: a retrospective cohort analysis.
Breast cancer research and treatment·2026
Circulating tumor cells in lobular versus ductal metastatic breast cancer.
Breast cancer research and treatment·2026
Efficacy and toxicity for pembrolizumab-containing therapy in older adults with triple-negative breast cancer: insights from routine oncology practice.
Breast cancer research and treatment·2026
Risk of malignancy after diagnosis of radial sclerosing lesion with associated atypia.
Breast cancer research and treatment·2026
Change in alcohol consumption and all-cause mortality among postmenopausal women diagnosed with breast cancer.
Breast cancer research and treatment·2026
Recent trends in race and ethnicity reporting in breast surgery journals.
Breast cancer research and treatment·2026